Net Loss Per Share

12 Months Ended

Dec. 31, 2024

Diluted loss per share considers the impact of potentially dilutive securities. We identified financial instruments that qualify as potential common shares: (i) the share-based options awards described in Note 13 (Stock-based Compensation), (ii) the warrants described in Note 7 (Warrant Liabilities), and (iii) the earnout liabilities described in Note 8 (Earnout Liabilities). Each of these potential common shares are antidilutive since their conversion to common shares would decrease loss per share from continuing operations.

Basic and diluted net loss per share attributable to common stockholders is calculated as follows:


	Year Ended December 31,
	2024		2023
Net loss attributable to holders of Common Stock	$	(116,272)	$	(61,018)
Basic weighted-average shares of Common Stock outstanding	91,164,286		89,539,910
Basic net loss per share for the period attributable to holders of Common Stock	$	(1.28)	$	(0.68)
Effect of dilutive securities:

Dilutive numerator	$	(116,272)	$	(61,018)

Diluted weighted-average Common Stock outstanding	91,164,286		89,539,910
Diluted net loss per share for the period attributable to holders of Common Stock	$	(1.28)	$	(0.68)

Additionally, the following securities were not included in the computation of diluted shares outstanding because the effect would have been anti-dilutive:


	Year Ended December 31,
	2024	2023
Warrants	49,184,815	49,184,868
Sponsor earnout shares	1,775,962	1,775,962
Stock options	3,234,296	4,909,302
Restricted stock units	2,893,396	3,229,915
Shares convertible from Secured Convertible Notes	25,000,000	—
Total	82,088,469	59,100,047